Skip to content

Effects of the multidisciplinary collaborative weight loss program in obese or overweight cases with type 2 diabetes mellitus: a randomized controlled trial

Effects of the multidisciplinary collaborative weight loss program in obese or overweight cases with type 2 diabetes mellitus: a randomized controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000029321
Enrollment
Unknown
Registered
2020-01-24
Start date
2016-07-01
Completion date
Unknown
Last updated
2020-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Interventions

The experimental group:Online + offline weight reduction management team intervention
The control group:Formulation and face-to-face guidance of monthly single weight reduction plan

Sponsors

The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) Type 2 diabetes according to the WHO diagnosis and classification of diabetes in 1999; (2) aged between 18 and 60 years; (3) 24 kg/m2 <BMI<40 kg/m2; (4) clear consciousness, reading ability, and good communication with investigators; (5) ability to use smartphones; (6) blood pressure < 160/100 mmHg; (7) triglyceride < 6.77 mmol/L; (8) tolerance of extreme exercise.

Exclusion criteria

Exclusion criteria: (1) complications of severe heart, brain, kidney, eye and foot diseases, e.g., proliferative retinopathy, stage IV nephropathy or Cr>2 mg/dl, severe cardiovascular and cerebrovascular diseases, and cardiopulmonary exercise test intolerance; (2) unstable angina, blood pressure over 200/100 mmHg or co-infection; (3) mental disorders; (4) cancer, with radiotherapy and chemotherapy in the past six months; (5) participation in other trials; (6) condition requiring hypoglycemic drug discontinuation.

Design outcomes

Primary

MeasureTime frame
SDSCA;diabetic quality of life, DSQL;FBG;2HBG;HbA1c;Analysis of human body composition;Blood pressure;BMI;Hipline;Waist;Blood fat;

Countries

China

Contacts

Public ContactYUN HAN

The Affiliated Changzhou 2nd People's Hospital of Nanjing Medical University

10862281@qq.com+86 13914346926

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026